Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ngm Biopharmaceuticals Inc
(NQ:
NGM
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ngm Biopharmaceuticals Inc
< Previous
1
2
3
4
5
Next >
NGM Bio Announces Closing of Tender Offer
April 05, 2024
From
NGM Biopharmaceuticals, Inc.
Via
GlobeNewswire
NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting
March 19, 2024
From
NGM Biopharmaceuticals, Inc.
Via
GlobeNewswire
NGM BIOPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NGM Biopharmaceuticals, Inc. - NGM
March 13, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Looking Into NGM Biopharmaceuticals's Recent Short Interest
January 19, 2024
Via
Benzinga
Why NGM Biopharmaceuticals Stock Is Blasting Higher
January 02, 2024
NGM Biopharmaceuticals, Inc.
Via
Benzinga
NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results
March 11, 2024
From
NGM Biopharmaceuticals, Inc.
Via
GlobeNewswire
NGM BIOPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NGM Biopharmaceuticals, Inc. - NGM
February 27, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 26, 2024
Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results.
Via
Benzinga
Why Is Cancer-Focused NGM Biopharmaceuticals Stock Trading Lower On Monday?
February 26, 2024
Explore NGM Bio's acquisition news by The Column Group at $1.55/share, an 80% premium. Learn about the recent Phase 1b study findings.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 26, 2024
Via
Benzinga
NGM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NGM Biopharmaceuticals, Inc. Is Fair to Shareholders
February 26, 2024
From
Halper Sadeh LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. (NYSE – AGTI), NGM Biopharmaceuticals, Inc. (Nasdaq – NGM), VIZIO Holding Corp. (NYSE - VZIO), HireRight Holdings Corporation (NYSE – HRT)
February 26, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP
February 26, 2024
From
NGM Biopharmaceuticals, Inc.
Via
GlobeNewswire
NGM Bio to Participate in the Cowen 44th Annual Health Care Conference
February 20, 2024
From
NGM Biopharmaceuticals, Inc.
Via
GlobeNewswire
NGM Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference
January 17, 2024
From
NGM Biopharmaceuticals, Inc.
Via
GlobeNewswire
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 09, 2024
Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.
Via
Benzinga
NGM Bio Announces New Clinical Data from Ongoing Trial of NGM707 in Advanced Solid Tumors and Outlines Evolved Strategy for Aldafermin and NGM120 to Focus on Rare Conditions with Significant Unmet Need
January 09, 2024
From
NGM Biopharmaceuticals, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 29, 2023
Via
Benzinga
B. Riley Securities Maintains Buy Rating for NGM Biopharmaceuticals: Here's What You Need To Know
November 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 20, 2023
Via
Benzinga
NGM Bio Presents Positive Phase 2b Results from the ALPINE 4 Trial of Aldafermin in Patients with Compensated Cirrhosis (F4) Due to NASH at AASLD The Liver Meeting®
November 13, 2023
From
NGM Biopharmaceuticals, Inc.
Via
GlobeNewswire
NGM Bio to Participate in Upcoming Investor Conferences
November 07, 2023
From
NGM Biopharmaceuticals, Inc.
Via
GlobeNewswire
NGM Bio Reports Third Quarter 2023 Financial Results and Provides Business Highlights
November 02, 2023
From
NGM Biopharmaceuticals, Inc.
Via
GlobeNewswire
Why Pinterest Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
October 31, 2023
Gainers LumiraDx Limited (NASDAQ: LMDX) shares surged 38.8% to $0.1250 in pre-market trading. LumiraDX shares fell 25% on Monday after the company announced the receipt of the Nasdaq delisting...
Via
Benzinga
NGM Bio Announces Oral Plenary Presentation of Data from Phase 2b ALPINE 4 Trial of Aldafermin in Compensated Cirrhosis (F4) Due to NASH at Upcoming AASLD The Liver Meeting®
October 11, 2023
From
NGM Biopharmaceuticals, Inc.
Via
GlobeNewswire
Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 12, 2023
Gainers
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 07, 2023
On Thursday, 283 companies set new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.